Suppr超能文献

症状性颅内动脉粥样硬化性疾病患者的危险因素控制与早期复发性脑梗死

Risk Factors Control and Early Recurrent Cerebral Infarction in Patients with Symptomatic Intracranial Atherosclerotic Disease.

作者信息

Del Brutto Victor J, Liebeskind David S, Romano Jose G, Campo-Bustillo Iszet, Cotsonis George, Nizam Azhar, Prabhakaran Shyam

机构信息

Department of Neurology, University of Miami Miller School of Medicine, Miami, FL.

University of California at Los Angeles, Los Angeles, CA.

出版信息

J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105914. doi: 10.1016/j.jstrokecerebrovasdis.2021.105914. Epub 2021 Jun 30.

Abstract

BACKGROUND

The risk of early recurrent cerebral infarction (RCI) is high in patients with symptomatic intracranial atherosclerotic disease (IAD). We sought to determine the relationship between risk factor control and early RCI risk among patients with symptomatic IAD.

METHODS

We analyzed participants with symptomatic IAD in the multi-center prospective observational MYRIAD study. Risk factor control was assessed at 6-8-week follow-up. Optimal risk factor control was defined by target systolic blood pressure, being non-smoker, target physical activity, and antiplatelet and antilipidemic therapy compliance. Age-adjusted associations were calculated between risk factor control and RCI determined by MRI-evident new infarcts in the territory of the stenotic vessel at 6-8 weeks from the index event.

RESULTS

Among 82 participants with clinical and brain MRI information available 6-8 weeks after the index event (mean age 63.5 ±12.5 years, 62.2% men), RCI occurred in 21 (25.6%) cases. At 6-8-week follow-up, 37.8% had target systolic blood pressure, 92.7% were non-smokers, 51.2% had target physical activity, and 98.8% and 86.6% were compliant with antiplatelet and antilipidemic therapy, respectively. Optimal risk factor control increased from 4.9% at baseline to 19.5% at 6-8-week follow-up (p=0.01). None of the participants with optimal risk factor control at follow-up had RCI (0% vs. 31.8%, p<0.01).

CONCLUSIONS

Only one-fifth of MYRIAD participants had optimal risk factor control during early follow-up. Approximately half and two-thirds had physical inactivity and uncontrolled systolic blood pressure, respectively. These risk factors may represent important therapeutic targets to prevent early RCI in patients with symptomatic IAD.

摘要

背景

有症状的颅内动脉粥样硬化疾病(IAD)患者早期复发性脑梗死(RCI)风险很高。我们试图确定有症状IAD患者的危险因素控制与早期RCI风险之间的关系。

方法

我们分析了多中心前瞻性观察性MYRIAD研究中有症状IAD的参与者。在6-8周随访时评估危险因素控制情况。最佳危险因素控制定义为目标收缩压、非吸烟者、目标体力活动以及抗血小板和降脂治疗依从性。计算了危险因素控制与RCI之间的年龄调整关联,RCI由索引事件后6-8周时狭窄血管区域内MRI显示的新梗死灶确定。

结果

在索引事件后6-8周有临床和脑MRI信息的82名参与者中(平均年龄63.5±12.5岁,62.2%为男性),21例(25.6%)发生了RCI。在6-8周随访时,37.8%达到目标收缩压,92.7%为非吸烟者,51.2%有目标体力活动,抗血小板和降脂治疗的依从性分别为98.8%和86.6%。最佳危险因素控制从基线时的4.9%增加到6-8周随访时的19.5%(p=0.01)。随访时最佳危险因素控制的参与者均未发生RCI(0%对31.8%,p<0.01)。

结论

在早期随访期间,MYRIAD参与者中只有五分之一达到了最佳危险因素控制。分别约有一半和三分之二的参与者体力活动不足和收缩压未得到控制。这些危险因素可能是预防有症状IAD患者早期RCI的重要治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbe/8384672/4555a4512f6b/nihms-1720509-f0001.jpg

相似文献

2
Early aggressive medical management for patients with symptomatic intracranial stenosis.有症状性颅内狭窄患者的早期积极医疗管理。
J Stroke Cerebrovasc Dis. 2013 Jan;22(1):87-91. doi: 10.1016/j.jstrokecerebrovasdis.2011.06.012. Epub 2011 Jul 26.
5
Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study.颅内动脉粥样硬化性梗死复发:来自 MyRIAD 研究的结果。
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105504. doi: 10.1016/j.jstrokecerebrovasdis.2020.105504. Epub 2020 Dec 1.
8
Management of Symptomatic Intracranial Stenosis.有症状颅内狭窄的管理
Curr Cardiol Rep. 2016 Sep;18(9):83. doi: 10.1007/s11886-016-0762-5.
9
Current and future concepts in stroke prevention.中风预防的当前及未来概念
CMAJ. 2004 Mar 30;170(7):1123-33. doi: 10.1503/cmaj.1031185.

本文引用的文献

1
Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study.颅内动脉粥样硬化性梗死复发:来自 MyRIAD 研究的结果。
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105504. doi: 10.1016/j.jstrokecerebrovasdis.2020.105504. Epub 2020 Dec 1.
5
Management of Blood Pressure After Acute Ischemic Stroke.急性缺血性脑卒中后血压管理。
Curr Neurol Neurosci Rep. 2019 Apr 29;19(6):29. doi: 10.1007/s11910-019-0941-z.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验